Latest News

A combination of two immunotherapy drugs benefits people with kidney cancer

Results from the RAMPART trial show that giving durvalumab and tremelimumab after surgery helps prevent kidney cancer coming back.

21 Oct

Weekly chemotherapy with bevacizumab improves ovarian cancer survival compared to having it once every three weeks

New results from the ICON8B trial were presented at the ESMO 2025 Conference.

20 Oct

Largest-ever Parkinson’s disease trial opens across UK

Using our multi-arm, multi-stage design, the EJS ACT-PD clinical trial aims to slow or stop the progression of Parkinsons’ disease.

16 Oct

Spotlight on our research at ESMO Congress 2025

We will present our latest cancer research from the RAMPART, ICON8B and STAMPEDE trials and STOPCAP meta-analysis at the 2025 ESMO Congress.

06 Oct

More News

In 2024, we celebrated our 25th anniversary. That's 25 years of smarter studies, global impact and better health. '25 at 25' is a series of articles highlighting 25 of our major achievements in that time.

Research Themes

Cancer cells

Cancer

Innovative clinical trial design and meta-analysis extending beyond the boundaries of single cancer types

 

Infections

Major international clinical trials answering questions of global public health significance

Neurodegenerative diseases

New generation of innovative multi-arm multi-stage trials to identify and test new therapeutic treatments in neurodegenerative diseases (NDD)

Methodology

Development of methods with direct impact on the design, conduct and analysis of studies

 

 

Other Research & Policy

This section will capture projects outside the current QQR themes

Latest Videos 

What are estimands?

RADICALS-HD trial results